OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
Mass spectrometry and automation are growing in importance for protein characterization.
Bioassay methods for cell and gene therapies require reevaluation.
Cell and gene therapy products pose challenges for extractable and leachable studies.
July 29, 2021
Thermo Fisher Scientific has added a new suite of immune repertoire assays that offers high detection rates of malignant clones, allowing researchers to better assess blood cancers.
Byondis and Glycotope have formed an agreement to discover and develop antibodies that target specific glyco-epitopes.
July 28, 2021
Following a deal struck in mid-2018, 908 Devices’ ZipChip and REBEL technology have proven instrumental in facilitating Transcenta’s efficiency and volumetric production.
Avantor’s newly unveiled J.T.Baker robotic tips is the latest in their line of automated precision plastics.
July 27, 2021
Sciex’s recently launched accurate mass instrument, the ZenoToff 7600 system, offers novel ion fragmentation and increased sensitivity for life science research and biotherapeutic development.
July 16, 2021
The ever-increasing complexity of biotherapeutic molecules presents unique analytical challenges for developers.
Developing analytical methods and bioassays is necessary from early on in the drug development life cycle.
Sponsors should consider best practices for maintaining data generated during sample analysis and instrument maintenance.
July 15, 2021
Gene therapy products present a unique set of challenges for the control of host cell protein impurities.
Sophisticated analytical technologies are complementing traditional approaches in the identification of residual process-related impurities of biotherapeutics.